BMRN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Biomarin Pharmaceutical Inc (BMRN).


$12.53B Market Cap.

As of 02/24/2025 5:00 PM ET (MRY) • Disclaimer

BMRN Market Cap. (MRY)


BMRN Shares Outstanding (MRY)


BMRN Assets (MRY)


Total Assets

$6.99B

Total Liabilities

$1.33B

Total Investments

$716.10M

BMRN Income (MRY)


Revenue

$2.85B

Net Income

$426.86M

Operating Expense

$1.79B

BMRN Cash Flow (MRY)


CF Operations

$572.84M

CF Investing

$136.49M

CF Financing

-$526.45M

BMRN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

BMRN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$6,988,940,000 (2.15%)

$6,841,603,000 (7.32%)

$6,375,074,000 (6.17%)

$6,004,772,000 (2.68%)

Assets Current

$3,232,427,000 (9.35%)

$2,956,088,000 (7.44%)

$2,751,457,000 (20.98%)

$2,274,385,000 (-2.90%)

Assets Non-Current

$3,756,513,000 (-3.32%)

$3,885,515,000 (7.23%)

$3,623,617,000 (-2.86%)

$3,730,387,000 (6.41%)

Goodwill & Intangible Assets

$451,477,000 (-8.03%)

$490,900,000 (-8.20%)

$534,768,000 (-8.56%)

$584,851,000 (-4.67%)

Shareholders Equity

$5,657,990,000 (14.27%)

$4,951,549,000 (7.57%)

$4,603,156,000 (7.91%)

$4,265,669,000 (3.89%)

Property Plant & Equipment Net

$1,043,041,000 (-2.17%)

$1,066,133,000 (-0.67%)

$1,073,366,000 (3.66%)

$1,035,461,000 (0.29%)

Cash & Equivalents

$942,842,000 (24.86%)

$755,127,000 (4.22%)

$724,531,000 (23.37%)

$587,276,000 (-9.53%)

Accumulated Other Comprehensive Income

$61,653,000 (314.16%)

-$28,788,000 (-644.45%)

-$3,867,000 (-126.79%)

$14,432,000 (189.42%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$716,102,000 (-22.98%)

$929,818,000 (3.22%)

$900,841,000 (-3.59%)

$934,392,000 (33.16%)

Investments Current

$194,864,000 (-38.85%)

$318,683,000 (-43.80%)

$567,006,000 (32.91%)

$426,599,000 (2.49%)

Investments Non-Current

$521,238,000 (-14.71%)

$611,135,000 (83.06%)

$333,835,000 (-34.26%)

$507,793,000 (77.88%)

Inventory

$1,232,653,000 (11.33%)

$1,107,183,000 (23.83%)

$894,083,000 (15.12%)

$776,669,000 (11.18%)

Trade & Non-Trade Receivables

$660,535,000 (4.23%)

$633,704,000 (37.37%)

$461,316,000 (23.55%)

$373,399,000 (-16.72%)

Trade & Non-Trade Payables

$606,988,000 (-11.15%)

$683,147,000 (19.23%)

$572,959,000 (14.99%)

$498,265,000 (1.16%)

Accumulated Retained Earnings (Deficit)

-$194,695,000 (68.68%)

-$621,554,000 (21.24%)

-$789,199,000 (15.21%)

-$930,760,000 (-8.03%)

Tax Assets

$1,489,366,000 (-3.65%)

$1,545,809,000 (2.68%)

$1,505,412,000 (3.81%)

$1,450,161,000 (1.26%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$595,138,000 (-45.25%)

$1,086,972,000 (0.36%)

$1,083,019,000 (0.37%)

$1,079,077,000 (0.37%)

Debt Current

$0 (0%)

$493,877,000 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$595,138,000 (0.34%)

$593,095,000 (-45.24%)

$1,083,019,000 (0.37%)

$1,079,077,000 (0.37%)

Total Liabilities

$1,330,950,000 (-29.58%)

$1,890,054,000 (6.67%)

$1,771,918,000 (1.89%)

$1,739,103,000 (-0.17%)

Liabilities Current

$606,988,000 (-48.43%)

$1,177,024,000 (99.87%)

$588,884,000 (7.76%)

$546,497,000 (10.95%)

Liabilities Non-Current

$723,962,000 (1.53%)

$713,030,000 (-39.73%)

$1,183,034,000 (-0.80%)

$1,192,606,000 (-4.55%)

BMRN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$2,853,915,000 (17.97%)

$2,419,226,000 (15.42%)

$2,096,039,000 (13.53%)

$1,846,275,000 (-0.76%)

Cost of Revenue

$580,235,000 (12.70%)

$514,854,000 (6.45%)

$483,669,000 (2.80%)

$470,515,000 (-10.25%)

Selling General & Administrative Expense

$1,009,025,000 (7.65%)

$937,291,000 (9.75%)

$854,009,000 (12.46%)

$759,375,000 (2.94%)

Research & Development Expense

$747,184,000 (0.06%)

$746,773,000 (14.96%)

$649,606,000 (3.31%)

$628,793,000 (0.11%)

Operating Expenses

$1,789,466,000 (2.47%)

$1,746,275,000 (19.38%)

$1,462,808,000 (0.32%)

$1,458,101,000 (5.69%)

Interest Expense

$12,666,000 (-26.93%)

$17,335,000 (8.55%)

$15,970,000 (4.13%)

$15,337,000 (-47.67%)

Income Tax Expense

$114,904,000 (449.31%)

$20,918,000 (160.99%)

$8,015,000 (171.12%)

-$11,270,000 (98.75%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$426,859,000 (154.62%)

$167,645,000 (18.43%)

$141,561,000 (320.91%)

-$64,080,000 (-107.50%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$426,859,000 (154.62%)

$167,645,000 (18.43%)

$141,561,000 (320.91%)

-$64,080,000 (-107.50%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$426,859,000 (154.62%)

$167,645,000 (18.43%)

$141,561,000 (320.91%)

-$64,080,000 (-107.50%)

Weighted Average Shares

$190,027,000 (1.17%)

$187,834,000 (1.39%)

$185,266,000 (1.32%)

$182,852,000 (1.13%)

Weighted Average Shares Diluted

$196,708,000 (2.67%)

$191,595,000 (1.39%)

$188,963,000 (3.34%)

$182,852,000 (-4.60%)

Earning Before Interest & Taxes (EBIT)

$554,429,000 (169.27%)

$205,898,000 (24.38%)

$165,546,000 (375.85%)

-$60,013,000 (-204.82%)

Gross Profit

$2,273,680,000 (19.39%)

$1,904,372,000 (18.11%)

$1,612,370,000 (17.20%)

$1,375,760,000 (2.96%)

Operating Income

$484,214,000 (206.28%)

$158,097,000 (5.71%)

$149,562,000 (281.64%)

-$82,341,000 (-89.55%)

BMRN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$136,491,000 (222.70%)

-$111,244,000 (-455.41%)

-$20,029,000 (94.53%)

-$366,313,000 (-583.15%)

Net Cash Flow from Financing

-$526,447,000 (-2711.17%)

-$18,727,000 (-0.41%)

-$18,650,000 (-38754.17%)

-$48,000 (-100.03%)

Net Cash Flow from Operations

$572,841,000 (259.69%)

$159,259,000 (-9.46%)

$175,902,000 (-42.24%)

$304,536,000 (256.75%)

Net Cash Flow / Change in Cash & Cash Equivalents

$187,715,000 (513.53%)

$30,596,000 (-77.71%)

$137,255,000 (321.80%)

-$61,882,000 (-129.23%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$222,768,000 (6231.79%)

-$3,633,000 (-144.38%)

$8,186,000 (103.33%)

-$246,094,000 (-1509.31%)

Capital Expenditure

-$75,424,000 (21.99%)

-$96,691,000 (-448.32%)

-$17,634,000 (81.55%)

-$95,578,000 (-102.70%)

Issuance (Repayment) of Debt Securities

-$494,987,000 (-21552.97%)

-$2,286,000 (12.25%)

-$2,605,000 (14.28%)

-$3,039,000 (-101.49%)

Issuance (Purchase) of Equity Shares

$49,277,000 (-28.95%)

$69,353,000 (0.03%)

$69,333,000 (40.94%)

$49,194,000 (124.50%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$4,830,000 (269.27%)

$1,308,000 (3987.50%)

$32,000 (156.14%)

-$57,000 (95.04%)

Share Based Compensation

$201,571,000 (-2.67%)

$207,099,000 (5.50%)

$196,308,000 (-0.48%)

$197,263,000 (3.98%)

Depreciation Amortization & Accretion

$96,426,000 (-7.63%)

$104,386,000 (2.37%)

$101,969,000 (-5.62%)

$108,039,000 (2.73%)

BMRN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

79.70% (1.27%)

78.70% (2.34%)

76.90% (3.22%)

74.50% (3.76%)

Profit Margin

15.00% (117.39%)

6.90% (1.47%)

6.80% (294.29%)

-3.50% (-107.63%)

EBITDA Margin

22.80% (78.13%)

12.80% (0.00%)

12.80% (392.31%)

2.60% (-43.48%)

Return on Average Equity (ROAE)

8.00% (128.57%)

3.50% (12.90%)

3.10% (306.67%)

-1.50% (-106.44%)

Return on Average Assets (ROAA)

6.10% (144.00%)

2.50% (8.70%)

2.30% (309.09%)

-1.10% (-107.10%)

Return on Sales (ROS)

19.40% (128.24%)

8.50% (7.59%)

7.90% (339.39%)

-3.30% (-200.00%)

Return on Invested Capital (ROIC)

9.90% (175.00%)

3.60% (20.00%)

3.00% (372.73%)

-1.10% (-175.00%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

29.21 (-73.04%)

108.34 (-20.44%)

136.17 (153.94%)

-252.43 (-1458.75%)

Price to Sales Ratio (P/S)

4.38 (-41.53%)

7.49 (-18.16%)

9.15 (4.54%)

8.75 (2.68%)

Price to Book Ratio (P/B)

2.21 (-39.64%)

3.67 (-12.21%)

4.18 (9.86%)

3.8 (-1.91%)

Debt to Equity Ratio (D/E)

0.23 (-38.48%)

0.38 (-0.78%)

0.39 (-5.64%)

0.41 (-3.77%)

Earnings Per Share (EPS)

2.25 (152.81%)

0.89 (17.11%)

0.76 (317.14%)

-0.35 (-107.42%)

Sales Per Share (SPS)

15.02 (16.60%)

12.88 (13.84%)

11.31 (12.05%)

10.1 (-1.88%)

Free Cash Flow Per Share (FCFPS)

2.62 (686.19%)

0.33 (-61.01%)

0.85 (-25.28%)

1.14 (441.71%)

Book Value Per Share (BVPS)

29.77 (12.95%)

26.36 (6.10%)

24.85 (6.50%)

23.33 (2.73%)

Tangible Assets Book Value Per Share (TABVPS)

34.4 (1.75%)

33.81 (7.25%)

31.52 (6.35%)

29.64 (2.38%)

Enterprise Value Over EBIT (EV/EBIT)

22 (-75.56%)

90 (-23.73%)

118 (142.45%)

-278 (66.55%)

Enterprise Value Over EBITDA (EV/EBITDA)

19.12 (-67.86%)

59.5 (-18.59%)

73.09 (-78.96%)

347.34 (81.59%)

Asset Turnover

0.41 (12.91%)

0.36 (8.01%)

0.34 (8.01%)

0.31 (-7.69%)

Current Ratio

5.33 (112.07%)

2.51 (-46.25%)

4.67 (12.25%)

4.16 (-12.47%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$497,417,000 (695.00%)

$62,568,000 (-60.47%)

$158,268,000 (-24.26%)

$208,958,000 (446.84%)

Enterprise Value (EV)

$12,446,200,642 (-32.59%)

$18,463,029,048 (-5.58%)

$19,554,022,213 (17.22%)

$16,681,429,894 (2.02%)

Earnings Before Tax (EBT)

$541,763,000 (187.31%)

$188,563,000 (26.07%)

$149,576,000 (298.51%)

-$75,350,000 (-53.78%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$650,855,000 (109.76%)

$310,284,000 (15.99%)

$267,515,000 (457.02%)

$48,026,000 (-43.82%)

Invested Capital

$5,582,771,000 (1.40%)

$5,505,524,000 (-1.86%)

$5,609,910,000 (4.56%)

$5,365,225,000 (3.82%)

Working Capital

$2,625,439,000 (47.57%)

$1,779,064,000 (-17.73%)

$2,162,573,000 (25.16%)

$1,727,888,000 (-6.58%)

Tangible Asset Value

$6,537,463,000 (2.94%)

$6,350,703,000 (8.74%)

$5,840,306,000 (7.76%)

$5,419,921,000 (3.54%)

Market Capitalization

$12,527,021,642 (-31.03%)

$18,162,459,048 (-5.57%)

$19,233,504,213 (18.58%)

$16,220,479,894 (1.90%)

Average Equity

$5,357,875,250 (11.10%)

$4,822,579,000 (6.77%)

$4,516,948,000 (6.69%)

$4,233,849,750 (15.71%)

Average Assets

$6,944,982,250 (4.45%)

$6,649,158,250 (7.04%)

$6,211,915,500 (4.91%)

$5,921,449,000 (7.51%)

Invested Capital Average

$5,621,277,500 (-0.37%)

$5,642,394,750 (1.77%)

$5,544,119,250 (4.68%)

$5,296,507,000 (15.12%)

Shares

190,583,016 (1.18%)

188,368,171 (1.36%)

185,848,915 (1.23%)

183,593,434 (1.14%)